Pergamum AB Report issue

For profit Phase 2
Founded: Solna Sweden (2009)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2009
NCT01022242
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

Key: Pergamum AB (0) Acquired (2)

dpk-060 (2 trials)

hyaluronic acid (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Otitis (Phase 2)

Otitis Externa (Phase 2)

Tissue Adhesions (Phase 2)

Overview

  • Highest Phase: None
  • # of Trials: 4
  • # of Trial APIs: 2